Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance

Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). To determine the relationship between in vivo pharmacological desensitization...

Full description

Saved in:
Bibliographic Details
Published inPsychopharmacology Vol. 184; no. 3-4; pp. 306 - 313
Main Authors Robinson, Susan E., James, John R., Lapp, Laura N., Vann, Robert E., Gross, Daniel F., Philibin, Scott D., Rosecrans, John A.
Format Journal Article
LanguageEnglish
Published Germany Springer Nature B.V 01.02.2006
Subjects
Online AccessGet full text
ISSN0033-3158
1432-2072
DOI10.1007/s00213-005-0049-9

Cover

Abstract Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function. Male Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an 86Rb+ efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus. The nicotine-induced increase in 86Rb+ efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic 86Rb+ efflux and the rate of behavioral desensitization of individual rats. These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level.
AbstractList Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs).RATIONALEIndividuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs).To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function.OBJECTIVETo determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function.Male Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an 86Rb+ efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus.METHODSMale Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an 86Rb+ efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus.The nicotine-induced increase in 86Rb+ efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic 86Rb+ efflux and the rate of behavioral desensitization of individual rats.RESULTSThe nicotine-induced increase in 86Rb+ efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic 86Rb+ efflux and the rate of behavioral desensitization of individual rats.These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level.CONCLUSIONThese findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level.
Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function. Male Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an 86Rb+ efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus. The nicotine-induced increase in 86Rb+ efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic 86Rb+ efflux and the rate of behavioral desensitization of individual rats. These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level.
Issue Title: Nicotine Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function. Male Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an 86Rb+ efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus. The nicotine-induced increase in 86Rb+ efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic 86Rb+ efflux and the rate of behavioral desensitization of individual rats. These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level. [PUBLICATION ABSTRACT]
Rationale: Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). Objective: To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function. Methods: Male Sprague-Dawley rats, trained to discriminate nicotine (0.4 mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4 mg/kg nicotine, tested for nicotine discrimination for 2 min, then injected with the same dose of nicotine 90 min, 180 min, and 270 min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an super(86)Rb super(+) efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and 'thalamus,' which included the midbrain and hypothalamus as well as the thalamus. Results: The nicotine-induced increase in super(86)Rb super(+) efflux was significantly greater in NDZ as compared to DZ in the 'thalamus.' There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic super(86)Rb super(+) efflux and the rate of behavioral desensitization of individual rats. Conclusion: These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level.
Rationale: Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the functional state of nicotinic cholinergic receptors (nAChRs). Objective: To determine the relationship between in vivo pharmacological desensitization (in other words, acute tolerance) and brain regional nAChR function. Methods: Male Sprague-Dawley rats, trained to discriminate nicotine (0.4mg/kg free base) from saline in a two-lever drug discrimination task, were tested for the development of acute tolerance. Rats were injected with 0.4mg/kg nicotine, tested for nicotine discrimination for 2min, then injected with the same dose of nicotine 90min, 180min, and 270min after the first injection and tested for nicotine discrimination after each injection. These subjects were separated into two groups, desensitizers (DZ) and nondesensitizers (NDZ), based upon performance in the repetitive dosing drug discrimination paradigm. The sensitivity of nAChRs in specific brain regions of these two groups was assessed by the use of an super(86)Rb super(+) efflux assay using synaptosomes prepared from the frontal cortex, hippocampus, striatum, and "thalamus," which included the midbrain and hypothalamus as well as the thalamus. Results: The nicotine-induced increase in super(86)Rb super(+) efflux was significantly greater in NDZ as compared to DZ in the "thalamus." There was no statistically significant difference in the effects of nicotine in the frontal cortex, hippocampus, and striatum of these two groups. A significant correlation was observed between thalamic super(86)Rb super(+) efflux and the rate of behavioral desensitization of individual rats. Conclusion: These findings are consistent with the concept that the production of acute tolerance by nicotine in vivo correlates directly with its ability to induce nAChR desensitization at the cellular level.
Author James, John R.
Philibin, Scott D.
Rosecrans, John A.
Gross, Daniel F.
Lapp, Laura N.
Vann, Robert E.
Robinson, Susan E.
Author_xml – sequence: 1
  givenname: Susan E.
  surname: Robinson
  fullname: Robinson, Susan E.
– sequence: 2
  givenname: John R.
  surname: James
  fullname: James, John R.
– sequence: 3
  givenname: Laura N.
  surname: Lapp
  fullname: Lapp, Laura N.
– sequence: 4
  givenname: Robert E.
  surname: Vann
  fullname: Vann, Robert E.
– sequence: 5
  givenname: Daniel F.
  surname: Gross
  fullname: Gross, Daniel F.
– sequence: 6
  givenname: Scott D.
  surname: Philibin
  fullname: Philibin, Scott D.
– sequence: 7
  givenname: John A.
  surname: Rosecrans
  fullname: Rosecrans, John A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16010542$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFOHSEUhkljU6-2D9CNIV20q2kPMAzDsjFaTUy6adeEYc4odi5cgTFtn16uV2PiQkmAhHz_IX--A7IXYkBCPjL4ygDUtwzAmWgAZN2tbvQbsmKt4A0HxffICkCIRjDZ75ODnK-hrrZv35F91gED2fIV-XNy60cMDmmcqMN5XmabaPAuFl9PmtDhpsRER8wYsi_-vy0-BuoDTbZkin-v_FCfw-VjChsfxsXhSK1bCtISZ0y2fvGevJ3snPHDw31Ifp-e_Do-ay5-_jg__n7RONHr0mg7dE5xcIMTHFoltOLDqDqctMbBCmFVO_UAE68VRMeV1XpEJiUMvR6FFYfky27uJsWbBXMxa5-33WzAuGSjZCul0hIq-flFslNdp4F3r4JM817x-4mfnoHXcUmh1jWc9VpJDn2Fjh6gZVjjaDbJr236Zx61VIDtAJdizgmnJwTMVr3ZqTdVvdmqN7pm1LOM8-XeVUnWzy8k7wBBdLI8
CitedBy_id crossref_primary_10_1002_ddr_20219
crossref_primary_10_1177_0269881118822074
crossref_primary_10_1016_j_brainres_2006_07_110
crossref_primary_10_1007_s00213_012_2814_x
crossref_primary_10_1007_s00213_006_0687_6
crossref_primary_10_1038_sj_npp_1301455
crossref_primary_10_1016_j_brainresbull_2011_05_011
crossref_primary_10_1016_j_neubiorev_2009_07_013
crossref_primary_10_1146_annurev_pharmtox_47_120505_105354
crossref_primary_10_2139_ssrn_4183131
crossref_primary_10_1038_oby_2008_221
crossref_primary_10_1016_j_brainres_2014_02_038
crossref_primary_10_1016_j_drugalcdep_2023_110900
crossref_primary_10_1016_j_yhbeh_2009_10_003
crossref_primary_10_1124_jpet_121_000978
crossref_primary_10_1016_j_nlm_2012_04_003
crossref_primary_10_1016_j_pbb_2008_01_018
crossref_primary_10_3390_toxics10110696
Cites_doi 10.1016/0740-5472(93)90041-Y
10.1002/(SICI)1098-2299(199607/08)38:3/4<222::AID-DDR11>3.0.CO;2-0
10.1016/0091-3057(81)90332-4
10.1016/S0169-328X(03)00171-2
10.1111/j.1749-6632.2002.tb04177.x
10.1007/BF00713026
10.1016/S0166-4328(00)00205-9
10.1037/0022-006X.61.5.723
10.1002/neu.10109
10.1016/S0166-4328(00)00198-4
10.1016/0165-6147(91)90638-9
10.1016/S0079-6123(08)62483-8
10.1007/BF02249336
10.1007/BF02245835
10.1124/mol.62.2.334
10.1007/BF00421360
10.1046/j.1471-4159.1994.63020561.x
10.1007/BF00429192
10.1523/JNEUROSCI.18-12-04461.1998
10.1113/jphysiol.1957.sp005838
10.1016/0376-8716(85)90077-8
10.1046/j.1471-4159.1994.63062125.x
10.1016/0166-4328(95)00245-6
10.1016/0361-9230(95)00007-0
10.1111/j.1471-4159.1985.tb04005.x
10.1007/978-1-4612-4974-0
10.1523/JNEUROSCI.19-12-04804.1999
ContentType Journal Article
Copyright Springer-Verlag 2006
Copyright_xml – notice: Springer-Verlag 2006
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QR
7RV
7TK
7X7
7XB
88E
88G
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
K9.
KB0
M0S
M1P
M2M
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7U7
C1K
7X8
DOI 10.1007/s00213-005-0049-9
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Chemoreception Abstracts
Nursing & Allied Health Database
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
Animal Behavior Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
ProQuest One Psychology
Toxicology Abstracts
Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-2072
EndPage 313
ExternalDocumentID 1440233431
16010542
10_1007_s00213_005_0049_9
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
Virginia
GeographicLocations_xml – name: United States--US
– name: Virginia
GroupedDBID .55
3SX
40D
40E
95.
95~
AAYXX
ABMNI
AGWIL
ALMA_UNASSIGNED_HOLDINGS
CITATION
KOW
N2Q
R9-
RHV
SBY
SOJ
X7M
~EX
-4W
-BR
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QR
7RV
7TK
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GNUQQ
K9.
M1P
M2M
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7U7
C1K
7X8
ID FETCH-LOGICAL-c389t-9ab6c720cbc320473972bd76ef99eba33a74f800f20543627a99de1550b89d3a3
IEDL.DBID 7X7
ISSN 0033-3158
IngestDate Fri Jul 11 12:30:17 EDT 2025
Thu Jul 10 22:32:13 EDT 2025
Fri Jul 11 06:12:32 EDT 2025
Thu Aug 14 11:22:24 EDT 2025
Sat Sep 28 07:44:59 EDT 2024
Thu Apr 24 22:52:11 EDT 2025
Tue Jul 01 00:39:55 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3-4
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c389t-9ab6c720cbc320473972bd76ef99eba33a74f800f20543627a99de1550b89d3a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 16010542
PQID 218975208
PQPubID 23462
PageCount 8
ParticipantIDs proquest_miscellaneous_754557950
proquest_miscellaneous_67669026
proquest_miscellaneous_19287250
proquest_journals_218975208
pubmed_primary_16010542
crossref_primary_10_1007_s00213_005_0049_9
crossref_citationtrail_10_1007_s00213_005_0049_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-02-01
PublicationDateYYYYMMDD 2006-02-01
PublicationDate_xml – month: 02
  year: 2006
  text: 2006-02-01
  day: 01
PublicationDecade 2000
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Heidelberg
PublicationTitle Psychopharmacology
PublicationTitleAlternate Psychopharmacology (Berl)
PublicationYear 2006
Publisher Springer Nature B.V
Publisher_xml – name: Springer Nature B.V
References MJ Marks (49_CR10) 1993; 264
JR James (49_CR7) 1994; 114
BM Sharp (49_CR29) 1986; 238
IP Stolerman (49_CR31) 1991; 12
ID Hirschhorn (49_CR5) 1974; 40
M Shoaib (49_CR30) 1996; 78
ELM Ochoa (49_CR18) 1989; 9
JA Rosecrans (49_CR23) 1991; 116
PP Rowell (49_CR27) 1994; 63
CP Fenster (49_CR4) 1999; 19
H Miyata (49_CR14) 2002; 965
T Nishizaki (49_CR16) 2003; 114
IP Stolerman (49_CR32) 1973; 30
BA Hulihan-Giblin (49_CR6) 1990; 252
MJ Marks (49_CR12) 1994; 63
KA Perkins (49_CR20) 1995; 118
MW Quick (49_CR22) 2002; 53
JA Rosecrans (49_CR24) 1993; 10
RD Schwartz (49_CR28) 1985; 45
KA Perkins (49_CR19) 1994; 270
X Zhang (49_CR35) 2000; 113
P Dobelis (49_CR3) 2002; 62
CI Bliss (49_CR1) 1967
MJ Marks (49_CR9) 1983; 224
OF Pomerleau (49_CR21) 1993; 61
JA Rosecrans (49_CR26) 1995; 37
MI Damaj (49_CR2) 1996; 277
JA Rosecrans (49_CR25) 1989; 79
LT Meltzer (49_CR13) 1981; 15
JL Wiley (49_CR34) 1996; 38
B Katz (49_CR8) 1957; 138
RJ Tallarida (49_CR33) 1986
A Nordberg (49_CR17) 1985; 16
M Zoli (49_CR36) 1998; 18
MJ Marks (49_CR11) 1993; 266
AH Mohammed (49_CR15) 2000; 113
2587745 - Prog Brain Res. 1989;79:239-48
7855204 - Psychopharmacology (Berl). 1994 Apr;114(3):456-62
8864050 - Behav Brain Res. 1996 Aug;78(2):183-8
8035180 - J Neurochem. 1994 Aug;63(2):561-9
7964732 - J Neurochem. 1994 Dec;63(6):2125-35
4064913 - Drug Alcohol Depend. 1985 Sep;16(1):9-17
8245270 - J Consult Clin Psychol. 1993 Oct;61(5):723-31
10942037 - Behav Brain Res. 2000 Aug;113(1-2):105-15
12436413 - J Neurobiol. 2002 Dec;53(4):457-78
13463799 - J Physiol. 1957 Aug 29;138(1):63-80
4009168 - J Neurochem. 1985 Aug;45(2):427-33
8071855 - J Pharmacol Exp Ther. 1994 Aug;270(2):628-38
12130686 - Mol Pharmacol. 2002 Aug;62(2):334-42
9614223 - J Neurosci. 1998 Jun 15;18(12):4461-72
2299587 - J Pharmacol Exp Ther. 1990 Jan;252(1):15-20
8437106 - J Pharmacol Exp Ther. 1993 Feb;264(2):542-52
4722204 - Psychopharmacologia. 1973 Jun 29;30(4):329-42
7620908 - Brain Res Bull. 1995;37(4):359-62
7291225 - Pharmacol Biochem Behav. 1981 Jul;15(1):21-6
8371136 - J Pharmacol Exp Ther. 1993 Sep;266(3):1268-76
10942030 - Behav Brain Res. 2000 Aug;113(1-2):35-41
4449931 - Psychopharmacologia. 1974;40(2):109-20
10366615 - J Neurosci. 1999 Jun 15;19(12):4804-14
12105111 - Ann N Y Acad Sci. 2002 Jun;965:354-63
8510190 - J Subst Abuse Treat. 1993 Mar-Apr;10(2):161-70
7617803 - Psychopharmacology (Berl). 1995 Mar;118(2):164-70
8613954 - J Pharmacol Exp Ther. 1996 Apr;277(1):454-61
1792691 - Trends Pharmacol Sci. 1991 Dec;12(12):467-73
3016239 - J Pharmacol Exp Ther. 1986 Aug;238(2):486-91
12829329 - Brain Res Mol Brain Res. 2003 Jun 10;114(2):172-6
2663167 - Cell Mol Neurobiol. 1989 Jun;9(2):141-78
1369662 - NIDA Res Monogr. 1991;(116):101-16
References_xml – volume: 277
  start-page: 454
  year: 1996
  ident: 49_CR2
  publication-title: J Pharmacol Exp Ther
– volume: 10
  start-page: 161
  year: 1993
  ident: 49_CR24
  publication-title: J Subst Abuse Treat
  doi: 10.1016/0740-5472(93)90041-Y
– volume: 38
  start-page: 222
  year: 1996
  ident: 49_CR34
  publication-title: Drug Dev Res
  doi: 10.1002/(SICI)1098-2299(199607/08)38:3/4<222::AID-DDR11>3.0.CO;2-0
– volume: 15
  start-page: 21
  year: 1981
  ident: 49_CR13
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(81)90332-4
– volume: 114
  start-page: 172
  year: 2003
  ident: 49_CR16
  publication-title: Brain Res Mol Brain Res
  doi: 10.1016/S0169-328X(03)00171-2
– volume: 965
  start-page: 354
  year: 2002
  ident: 49_CR14
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2002.tb04177.x
– volume: 9
  start-page: 141
  year: 1989
  ident: 49_CR18
  publication-title: Cell Mol Neurobiol
  doi: 10.1007/BF00713026
– volume: 266
  start-page: 1268
  year: 1993
  ident: 49_CR11
  publication-title: J Pharmacol Exp Ther
– volume: 113
  start-page: 105
  year: 2000
  ident: 49_CR35
  publication-title: Behav Brain Res
  doi: 10.1016/S0166-4328(00)00205-9
– volume: 61
  start-page: 723
  year: 1993
  ident: 49_CR21
  publication-title: J Consult Clin Psychol
  doi: 10.1037/0022-006X.61.5.723
– volume-title: Statistics in biology
  year: 1967
  ident: 49_CR1
– volume: 53
  start-page: 457
  year: 2002
  ident: 49_CR22
  publication-title: J Neurobiol
  doi: 10.1002/neu.10109
– volume: 116
  start-page: 101
  year: 1991
  ident: 49_CR23
  publication-title: NIDA Res Monogr
– volume: 238
  start-page: 486
  year: 1986
  ident: 49_CR29
  publication-title: J Pharmacol Exp Ther
– volume: 113
  start-page: 35
  year: 2000
  ident: 49_CR15
  publication-title: Behav Brain Res
  doi: 10.1016/S0166-4328(00)00198-4
– volume: 12
  start-page: 467
  year: 1991
  ident: 49_CR31
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/0165-6147(91)90638-9
– volume: 79
  start-page: 239
  year: 1989
  ident: 49_CR25
  publication-title: Prog Brain Res
  doi: 10.1016/S0079-6123(08)62483-8
– volume: 252
  start-page: 15
  year: 1990
  ident: 49_CR6
  publication-title: J Pharmacol Exp Ther
– volume: 114
  start-page: 456
  year: 1994
  ident: 49_CR7
  publication-title: Psychopharmacology
  doi: 10.1007/BF02249336
– volume: 118
  start-page: 164
  year: 1995
  ident: 49_CR20
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/BF02245835
– volume: 62
  start-page: 334
  year: 2002
  ident: 49_CR3
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.62.2.334
– volume: 40
  start-page: 109
  year: 1974
  ident: 49_CR5
  publication-title: Psychopharmacologia (Berl)
  doi: 10.1007/BF00421360
– volume: 63
  start-page: 561
  year: 1994
  ident: 49_CR27
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1994.63020561.x
– volume: 30
  start-page: 329
  year: 1973
  ident: 49_CR32
  publication-title: Psychopharmacologia
  doi: 10.1007/BF00429192
– volume: 18
  start-page: 4461
  year: 1998
  ident: 49_CR36
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.18-12-04461.1998
– volume: 138
  start-page: 63
  year: 1957
  ident: 49_CR8
  publication-title: J Physiol (Lond)
  doi: 10.1113/jphysiol.1957.sp005838
– volume: 16
  start-page: 9
  year: 1985
  ident: 49_CR17
  publication-title: Drug Alcohol Depend
  doi: 10.1016/0376-8716(85)90077-8
– volume: 63
  start-page: 2125
  year: 1994
  ident: 49_CR12
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.1994.63062125.x
– volume: 78
  start-page: 183
  year: 1996
  ident: 49_CR30
  publication-title: Behav Brain Res
  doi: 10.1016/0166-4328(95)00245-6
– volume: 37
  start-page: 359
  year: 1995
  ident: 49_CR26
  publication-title: Brain Res Bull
  doi: 10.1016/0361-9230(95)00007-0
– volume: 45
  start-page: 427
  year: 1985
  ident: 49_CR28
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.1985.tb04005.x
– volume: 270
  start-page: 628
  year: 1994
  ident: 49_CR19
  publication-title: J Pharmacol Exp Ther
– volume-title: Manual of pharmacology calculations with computer programs
  year: 1986
  ident: 49_CR33
  doi: 10.1007/978-1-4612-4974-0
– volume: 264
  start-page: 542
  year: 1993
  ident: 49_CR10
  publication-title: J Pharmacol Exp Ther
– volume: 224
  start-page: 806
  year: 1983
  ident: 49_CR9
  publication-title: J Pharmacol Exp Ther
– volume: 19
  start-page: 4804
  year: 1999
  ident: 49_CR4
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.19-12-04804.1999
– reference: 4722204 - Psychopharmacologia. 1973 Jun 29;30(4):329-42
– reference: 12105111 - Ann N Y Acad Sci. 2002 Jun;965:354-63
– reference: 2663167 - Cell Mol Neurobiol. 1989 Jun;9(2):141-78
– reference: 10942037 - Behav Brain Res. 2000 Aug;113(1-2):105-15
– reference: 1369662 - NIDA Res Monogr. 1991;(116):101-16
– reference: 12130686 - Mol Pharmacol. 2002 Aug;62(2):334-42
– reference: 8510190 - J Subst Abuse Treat. 1993 Mar-Apr;10(2):161-70
– reference: 7620908 - Brain Res Bull. 1995;37(4):359-62
– reference: 2299587 - J Pharmacol Exp Ther. 1990 Jan;252(1):15-20
– reference: 3016239 - J Pharmacol Exp Ther. 1986 Aug;238(2):486-91
– reference: 7617803 - Psychopharmacology (Berl). 1995 Mar;118(2):164-70
– reference: 8371136 - J Pharmacol Exp Ther. 1993 Sep;266(3):1268-76
– reference: 2587745 - Prog Brain Res. 1989;79:239-48
– reference: 4009168 - J Neurochem. 1985 Aug;45(2):427-33
– reference: 8245270 - J Consult Clin Psychol. 1993 Oct;61(5):723-31
– reference: 7855204 - Psychopharmacology (Berl). 1994 Apr;114(3):456-62
– reference: 7964732 - J Neurochem. 1994 Dec;63(6):2125-35
– reference: 10942030 - Behav Brain Res. 2000 Aug;113(1-2):35-41
– reference: 13463799 - J Physiol. 1957 Aug 29;138(1):63-80
– reference: 4064913 - Drug Alcohol Depend. 1985 Sep;16(1):9-17
– reference: 9614223 - J Neurosci. 1998 Jun 15;18(12):4461-72
– reference: 8071855 - J Pharmacol Exp Ther. 1994 Aug;270(2):628-38
– reference: 12436413 - J Neurobiol. 2002 Dec;53(4):457-78
– reference: 8613954 - J Pharmacol Exp Ther. 1996 Apr;277(1):454-61
– reference: 8035180 - J Neurochem. 1994 Aug;63(2):561-9
– reference: 12829329 - Brain Res Mol Brain Res. 2003 Jun 10;114(2):172-6
– reference: 7291225 - Pharmacol Biochem Behav. 1981 Jul;15(1):21-6
– reference: 8437106 - J Pharmacol Exp Ther. 1993 Feb;264(2):542-52
– reference: 4449931 - Psychopharmacologia. 1974;40(2):109-20
– reference: 8864050 - Behav Brain Res. 1996 Aug;78(2):183-8
– reference: 10366615 - J Neurosci. 1999 Jun 15;19(12):4804-14
– reference: 1792691 - Trends Pharmacol Sci. 1991 Dec;12(12):467-73
SSID ssj0000484
ssj0068394
Score 1.9403086
Snippet Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is dependent upon the...
Issue Title: Nicotine Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine...
Rationale: Individuals vary in their susceptibility to nicotine addiction. However, there is little evidence that behavioral sensitivity to nicotine is...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 306
SubjectTerms Animals
Brain - drug effects
Brain Mapping
Brain research
Conditioning, Operant - drug effects
Discrimination Learning - drug effects
Down-Regulation - drug effects
Drug dosages
Drug Tolerance
Laboratory animals
Male
Neurons - drug effects
Nicotine
Nicotine - pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Nicotinic - drug effects
Reinforcement schedules
Rubidium Radioisotopes - metabolism
Toxicology
Title Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance
URI https://www.ncbi.nlm.nih.gov/pubmed/16010542
https://www.proquest.com/docview/218975208
https://www.proquest.com/docview/19287250
https://www.proquest.com/docview/67669026
https://www.proquest.com/docview/754557950
Volume 184
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aBEovoU1f27SpDiWHElGvZEvWqWRLllDIspQE9mZkPSA02Nvae8i_z4wfu_SwudgYS0ZoxtI3o5n5AL5OXapsNJ5b5QVPo5Pc5EZzr_PMROVcacmhf71QV7fpr1W2GmJzmiGsclwTu4Xa14585N9xKzI6E0n-Y_2XE2kUHa4ODBrP4XCKQISYG_RK7xbilHIw-weFQKCvyCwpnyzLxxPOpCsoKojjgMLYEDBz8_8etQd4dhvQ_BUcDciRXfSifg3PQnUML66Hs_FjOFv2VagfztnNLqmqOWdnbLmrT_3wBv6MTKKsjowc9xSJyipUiZayJBmugWGNpjjzlJlEMV19qia7qxjqS8MCkWrfUbz02CtwNO1RSTyzbtMG1tb3gRg7wlu4nV_e_LziA-cCdwhdWm5sqZwWiSudFEmqEa6I0msVojGhtFJanUYEmVEg1sPNT1tjfCA7p8yNl1a-g4OqrsIHYKIUdoqXNKIcsuCsVDH3XlAPlVs5gWSc5cINBcmJF-O-2JZS7gRToGAKEkxhJvBt22XdV-N4qvHJKLpi-DGbYqtGE_iyfYt_FM22rUK9aQrEvLlGZLi_hdJKGTReJ8D2tNAITDNt6CPve6XZjZdM4CwVH58c3gm87J09FDjzCQ7af5vwGeFPW552Sn4Khxfz2WyB99nlYvn7EW6bBRI
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXBOW1FKgP0AOqReokdnxACAHVlnarHrbS3oLjh7SiShaSFdofxX9kJo9dcdjeeokUxbYiz3jmG88L4O2xTaQJ2nEjneBJsDHXmVbcqSzVQVpbGLrQn1zI8VXyfZbOduDvkAtDYZWDTGwFtass3ZF_QFWkVSqi7NPiF6emUeRcHTpodFxx5ld_0GKrP55-RfK-E-Lk2_TLmPdNBbhF3dxwbQpplYhsYWMRJQr1sSickj5o7QsTx0YlAVFUEAhmULoro7XzBOSLTLvYxLjuHbibkIcRj4-aqY3gTyjns3uRCDy6CtAx5a-l2eBRjdoCpoJ6KlDYHAJ0rv_XiVuAbqvwTh7Bwx6pss8daz2GHV_uwb1J74vfg8PLrur16ohNN0lc9RE7ZJebetirJ_Bz6FzKqsDIUUCRr6xEFmwoK5OhzPULNP2Zo0woiiHrUkPZvGTInzXz1MR7TvHZwyzP56VDpnTM2GXjWVNde-oQ4p_C1a2Q4xnsllXpXwAThTDH-EgC0iH11sQyZM4JmiEzE48gGnY5t30BdOrDcZ2vSze3hMmRMDkRJtcjeL-esuiqf9w0eH8gXd4Lgjpfs-0IDtZf8QTTbpvSV8s6R4ydKUSi20dIJaVGY3kEbMsIhUA4VZoWed4xzeZ_yeROE_Hyxt87gPvj6eQ8Pz-9ONuHB91FEwXtvILd5vfSv0bo1RRvWoZn8OO2T9g_N189_Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB5RkFAvVUsfLLTFh5ZDhUVwEjs-oKotrKCU1aoCiVvq2I60KkoWklW1P7H_qjN57KqH5cYlUhTbijzjmc_2zHwAH45sJE2uHTfSCR7lNuQ60Yo7lcQ6l9Zmhg70L0fy7Dr6fhPfrMHfPheGwip7m9gYaldaOiM_RFekVSyC5DDvoiLGJ8PP0ztOBFJ00dqzaZiOZcEdN9XGuhyPCz__g7u56vj8BEX_UYjh6dW3M94RDnCLfrvm2mTSKhHYzIYiiBT6apE5JX2utc9MGBoV5YiwcoFABy2_Mlo7TyA_S7QLTYjjPoEN7KdxH7jx9XQ0_rl0CxFlhLYvEmFJWx86pOy2OOnvW4OmvKkgxgUKqkP4zvX_HnMFDG7c4fA5POtwLPvSKt4LWPPFFmxedjf1W7A_bmtizw_Y1TLFqzpg-2y8rJY9fwm_e15TVuaMrhEoLpYVqKA15WwytMh-Wpf3zFGeFEWYtYmjbFIw1N6KeaL4nlD0dt_L80nhUGUdM3ZWe1aXt574Q_wruH4UgbyG9aIs_DYwkQlzhI8oRznE3ppQ5olzgnrIxIQDCPpZTm1XHp1YOm7TRWHnRjApCiYlwaR6AJ8WXaZtbZCHGu_2oks7M1GlC6UewN7iK65vmm1T-HJWpYjAE4U4dXULqaTUuJUeAFvRQiFMjpWmQd60SrP8X9qQx5HYefD39mATV1v643x0sQtP21Moiuh5C-v1_cy_Q1xWZ-87jWfw67EX2T9u8EjY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+of+cellular+nicotinic+receptor+desensitization+in+rats+exhibiting+nicotine-induced+acute+tolerance&rft.jtitle=Psychopharmacology&rft.au=Robinson%2C+Susan+E&rft.au=James%2C+John+R&rft.au=Lapp%2C+Laura+N&rft.au=Vann%2C+Robert+E&rft.date=2006-02-01&rft.issn=0033-3158&rft.volume=184&rft.issue=3-4&rft.spage=306&rft_id=info:doi/10.1007%2Fs00213-005-0049-9&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon